AIRS · AirSculpt Technologies, Inc.

AirSculpt Technologies filed this 8-K/A to amend its initial April 2, 2026 press release due to an inaccurate one-time non-cash adjustment related to the London facility closure, which impacted reported Adjusted EBITDA, Adjusted EBITDA Margin, and Adjusted Net (Loss)/Income figures. The correction reflects updated non-GAAP metrics, with reconciliations provided in Exhibit 99.1. For Q4 2025, revenue of $33.4 million declined 14.6% year-over-year amid a 15.0% drop in case volume to 2,604, driven by softer demand, though net loss improved to $1.3 million from $5.0 million, aided by lower operating expenses including a $2.7 million reclassification benefit from asset impairments tied to the London closure. Full year 2025 saw revenue fall 15.8% to $151.8 million on 15.6% lower case volume of 11,852, with net loss expanding to $11.7 million versus $8.0 million prior year, reflecting higher SG&A partially offset by cost reductions. Adjusted EBITDA declined to $12.5 million from $21.0 million. CEO Yogi Jashnani highlighted sequential same-store sales improvement in Q4, strategic enhancements including new talent, processes, go-to-market strategy, and procedures, positioning the company at the aesthetics-GLP-1 intersection, with same-store sales turning positive in February 2026. Balance sheet as of December 31, 2025 showed $8.4 million cash, $56.0 million gross debt, and covenant compliance. In Q1 2026, $14.8 million was raised via ATM offering, reducing debt to $45.0 million. Guidance for full year 2026 projects revenue of $151-157 million and Adjusted EBITDA of $15-17 million, with Q1 revenue at $38.5-39.5 million implying flat same-store at midpoint, signaling stabilization efforts.